Colombia Approval Marks 67th Country for Technegas

Cyclopharm Limited (ASX: CYC) is pleased to announce that Technegas® has received regulatory approval in Colombia, expanding the number of countries in which Technegas is approved for clinical use to 67 worldwide. This approval expands Cyclopharm’s global presence in functional lung imaging and supports the Company’s strategy of increasing access along with expanding the use of true functional ven